InvestorNewsBreaks – VistaGen Therapeutics Inc. (NASDAQ: VTGN) Appoints Highly Accomplished Finance Professional as CFO
Vistagen (NASDAQ: VTGN) is a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (“CNS”) disorders. The company today announced its appointment of Cindy Anderson as chief financial officer (“CFO”), effective Aug. 21, 2023. Anderson succeeds Jerrold Dotson, whose planned retirement was announced in July of this year. “We are delighted to welcome…